Shandong Luning Pharmaceutical Co., Ltd. was established in 2012 and covers an area of 80,000 square meters. The company has a solid preparation workshop, a synthetic raw material workshop, a drug research and development center and complete supporting facilities. , Established a municipal key laboratory, is a modern enterprise that meets the specifications of the pharmaceutical industry."Independent R & D strategic cooperation" is the guarantee for better and faster development of Luning Pharmaceutical. The company has established strategic cooperative relations with universities and research institutes such as the Chinese Academy of Sciences, Shanghai Jiaotong University, Shandong University Pharmaceutical College, and Tsinghua University doctoral team and research units The medicine involves anti-tumor, anti-depression, cardio-cerebrovascular, hypoglycemic, and immunity enhancement. Among them, the academician workstation was established in cooperation with Academician Yan Deyue of Shanghai Jiaotong University, and joint development of an innovative drug-nano-targeted anti-tumor drug (MTS). The pharmaceutical technology has achieved a major breakthrough. Drug resistance.The company focuses on the development and production of raw materials and preparations. The existing products include gentamicin granules, lysozyme lozenges, heparin sodium lozenges, sulfadiazine yellow tablets, aglitin, tadalafil, and azisa. Tanzania, agomelatine, vitamin B6, lipoic acid and its intermediates.The company is committed to the large health industry, and will create an industrial cluster that focuses on pharmaceuticals, combining health products and high-end medical devices, and strives to become a company with unique competitive advantages and contribute to human health.